These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7615052)

  • 21. Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: a review and updated results of the Australian Leukemia Study Group.
    Bishop JF; Matthews JP; Young GA; Bradstock K; Lowenthal RM
    Leuk Lymphoma; 1998 Jan; 28(3-4):315-27. PubMed ID: 9517503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia.
    Liu Yin JA; Johnson PR; Davies JM; Flanagan NG; Gorst DW; Lewis MJ
    Br J Haematol; 1991 Nov; 79(3):415-20. PubMed ID: 1751369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term remission of acute myeloid leukaemia with trilineage myelodysplasia treated solely with low dose cytarabine.
    Jack FR; Summerfield GP
    Clin Lab Haematol; 1994 Jun; 16(2):197-200. PubMed ID: 7955930
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytosine arabinoside and herpes zoster.
    Mann JR
    Lancet; 1971 Jul; 2(7716):166. PubMed ID: 4104494
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose cytosine arabinoside in the treatment of resistant acute leukemia.
    Takaku F; Urabe A; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):144-9. PubMed ID: 3859929
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-remission chemotherapy for acute myeloid leukemia.
    Atkins CD
    N Engl J Med; 1995 Feb; 332(5):334; author reply 334-5. PubMed ID: 7816076
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of acute transformation in chronic granulocytic leukaemia with low-dose cytosine arabinoside.
    Gallo JH; McKinley R; Grace CS; Rozenberg MC
    Br J Haematol; 1985 Nov; 61(3):586-8. PubMed ID: 3864488
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combined treatment of myeloid leukemia with cytosine arabinoside and 6-mercaptopurine].
    Lawkowicz W; Polubiec A; Domańska B
    Pol Tyg Lek; 1973 Jun; 28(23):865-7. PubMed ID: 4515923
    [No Abstract]   [Full Text] [Related]  

  • 29. All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients.
    Di Febo A; Laurenti L; Falcucci P; Tosti ME; Fianchi L; Pagano L; Leone G
    Am J Ther; 2007; 14(4):351-5. PubMed ID: 17667210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitozantrone and cytosine arabinoside as first line therapy in elderly patients with acute myeloid leukaemia. Trent Working Party on Adult Leukaemia.
    Hutchinson RM; Winfield DA
    Br J Haematol; 1992 Mar; 80(3):416-7. PubMed ID: 1581225
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.
    Poth JL; Johnson PK; George RP; Schrier SL
    Calif Med; 1972 Dec; 117(6):1-11. PubMed ID: 4508367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin.
    Taub JW; Stout ML; Buck SA; Huang X; Vega RA; Becton DL; Ravindranath Y
    Leukemia; 1997 Sep; 11(9):1594-5. PubMed ID: 9305619
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia.
    Braess J; Jahns-Streubel G; Schoch C; Haase D; Haferlach T; Fiegl M; Voss S; Kern W; Schleyer E; Hiddemann W
    Br J Haematol; 2001 Jun; 113(4):975-82. PubMed ID: 11442492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytosine-arabinoside in the treatment of acute myeloblastic leukemias].
    Maroncelli P; Canova R; Casalino C; Fischioni P
    Minerva Med; 1971 Mar; 62(21):1110-9. PubMed ID: 5279670
    [No Abstract]   [Full Text] [Related]  

  • 37. Is intensive treatment beneficial to elderly patients with ANLL?
    Harousseau JL
    Hematol Oncol; 1993; 11 Suppl 1():4-8. PubMed ID: 8486341
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intensive post-remission therapy of acute myeloid leukemia with high doses of cytosine arabinoside].
    Slechtová J; Koza V; Svojgrová M; Cepelák V
    Cas Lek Cesk; 1989 Sep; 128(39):1239-42. PubMed ID: 2582468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukaemia: results of the New Zealand AML-1 study. The Leukaemia Study Group of the New Zealand Society for Haematology.
    N Z Med J; 1991 Oct; 104(922):438-40. PubMed ID: 1923103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
    Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
    Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.